Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs and Disease Flare in Patients With Rheumatoid Arthritis. (2021)
Attributed to:
MICA: BIOlogical Factors that Limit sustAined Remission in rhEumatoid arthritis (the BIO-FLARE study)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1001/jama.2021.10648
PubMed Identifier: 34547087
Publication URI: http://europepmc.org/abstract/MED/34547087
Type: Journal Article/Review
Volume: 326
Parent Publication: JAMA
Issue: 9
ISSN: 0098-7484